Global Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Opp

Global Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Opportunity Analysis and Industry Forecast, 2020–2027

The global self-monitoring blood glucose devices market was valued at $8,490.79 million in 2019, and is projected to reach $11,991.98 million by 2027, growing at a CAGR of 4.2% from 2020 to 2027. Diabetes is a clinical condition where a person has an elevated blood glucose level caused due to inefficiency of pancreases to produce insulin. Glucose monitoring is one of the essential steps towards diabetes management by testing the glucose levels in blood.

Monitoring of blood glucose provides important data for patients to make daily management decisions such as food intake, insulin dose, and physical exercise. Self-monitoring blood glucose (SMBG) is a modern diabetes management procedure, which involves usage of blood glucose meters by patients to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. SMBG technology uses test strips, lancets, and blood glucose meters to achieve long-term glycemic control.

Factors such as increase in incidence rate of diabetes and rise in risk factors that lead to diabetes are the key factors driving the growth of the global self-monitoring blood glucose devices market. Moreover, technological advancements in the field of diabetes monitoring devices and rise in geriatric population boost the market growth. However, blood glucose monitoring devices do not measure the exact level of glucose in blood and can give inaccurate results, which hamper the market growth. Conversely, high growth potential in untapped markets and rise in awareness about diabetes monitoring devices are expected to provide lucrative opportunities for the expansion of the global market in the near future.

The self-monitoring blood glucose devices market is segmented into product, application, end user, and region. Depending on product, the market is divided into test strips, lancets, and blood glucose meters. The applications covered in the study include 1 diabetes, type 2 diabetes, and gestational diabetes. On the basis of end user, the market is fragmented into hospitals, home settings, and diagnostic centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides extensive competitive analysis and profiles of key market players such as Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings, LLC, PHC Holdings Corporation, Terumo Corporation, Trividia Health, Inc. (Sinocare Inc.), ARKRAY, Inc., and Ypsomed Holding AG.

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the current market trends from 2019 to 2027 to identify the prevailing opportunities.
Self-monitoring blood glucose devices market size and market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on region assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Key Market Segments

By Product

Test Strips
Lancets
Blood Glucose Meters

By Application

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

By End User

Hospitals
Home Settings
Diagnostic Centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

List of key players profiled in the report

Abbott Laboratories
Bionime Corporation
B. Braun Melsungen AG
F. Hoffmann-La Roche Ltd.
LifeScan IP Holdings, LLC
PHC Holdings Corporation
Terumo Corporation
Trividia Health, Inc. (Sinocare Inc.)
ARKRAY, Inc.
Ypsomed Holding AG

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Apex Biotechnology Corp.
Beurer GmbH
Dariohealth Corp.


CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key Findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market share analysis, 2019 (%)
3.4.Porter’s five forces analysis
3.4.1.Moderate bargaining power of buyers
3.4.2.High Bargaining Power of Suppliers
3.4.3.Low Threat of Substitution
3.4.4.Moderate Threat of New Entrant
3.4.5.High Competitive rivalry
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in the incidence rate of diabetes
3.5.1.2.Rise in geriatric population
3.5.1.3.Technological advancements in diabetes monitoring devices
3.5.1.4.Rise in risk factors that lead to diabetes
3.5.2.Restraints
3.5.2.1.Inaccurate results
3.5.3.Opportunity
3.5.3.1.Increase in awareness for diabetes monitoring devices
3.5.3.2.Untapped market opportunities in the developing regions
3.5.4.Impact analyses
3.6.Impact analysis of COVID-19 on self-monitoring blood glucose devices market
CHAPTER 4:SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast, by product
4.1.2.Market size and forecast, by product (million units)
4.2.Test strips
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Lancets
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Blood glucose meters
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast, by revenue
5.2.Type 1 diabetes
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Type 2 diabetes
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Gestational diabetes
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Home settings
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Diagnostic centers
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. market size and forecast, by product
7.2.2.1.2.U.S. market size and forecast, by application
7.2.2.1.3.U.S. market size and forecast, by end user
7.2.2.1.4.Market share analysis, for 2019
7.2.2.2.Canada
7.2.2.2.1.Canada market size and forecast, by product
7.2.2.2.2.Canada market size and forecast, by application
7.2.2.2.3.Canada market size and forecast, by end user
7.2.2.2.4.Market share analysis, for 2019
7.2.2.3.Mexico
7.2.2.3.1.Mexico market size and forecast, by product
7.2.2.3.2.Mexico market size and forecast, by application
7.2.2.3.3.Mexico market size and forecast, by end user
7.2.2.3.4.Market share analysis, for 2019
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe self-monitoring blood glucose devices market, by country
7.3.2.1.Germany
7.3.2.1.1.Germany market size and forecast, by product
7.3.2.1.2.Germany market size and forecast, by application
7.3.2.1.3.Germany market size and forecast, by end user
7.3.2.1.4.Market share analysis, for 2019
7.3.2.2.France
7.3.2.2.1.France market size and forecast, by product
7.3.2.2.2.France market size and forecast, by application
7.3.2.2.3.France market size and forecast, by end user
7.3.2.2.4.Market share analysis, for 2019
7.3.2.3.UK
7.3.2.3.1.UK market size and forecast, by product
7.3.2.3.2.UK market size and forecast, by application
7.3.2.3.3.UK market size and forecast, by end user
7.3.2.3.4.Market share analysis, for 2019
7.3.2.4.Italy
7.3.2.4.1.Italy market size and forecast, by product
7.3.2.4.2.Italy market size and forecast, by application
7.3.2.4.3.Italy market size and forecast, by end user
7.3.2.4.4.Market share analysis, for 2019
7.3.2.5.Spain
7.3.2.5.1.Spain market size and forecast, by product
7.3.2.5.2.Spain market size and forecast, by application
7.3.2.5.3.Spain market size and forecast, by end user
7.3.2.5.4.Market share analysis, for 2019
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe market size and forecast, by product
7.3.2.6.2.Rest of Europe market size and forecast, by application
7.3.2.6.3.Rest of Europe market size and forecast, by end user
7.3.2.6.4.Market share analysis, for 2019
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan market size and forecast, by product
7.4.2.1.2.Japan market size and forecast, by application
7.4.2.1.3.Japan market size and forecast, by end user
7.4.2.1.4.Market share analysis, for 2019
7.4.2.2.China
7.4.2.2.1.China market size and forecast, by product
7.4.2.2.2.China market size and forecast, by application
7.4.2.2.3.China market size and forecast, by end user
7.4.2.2.4.Market share analysis, for 2019
7.4.2.3.India
7.4.2.3.1.India market size and forecast, by product
7.4.2.3.2.India market size and forecast, by application
7.4.2.3.3.India market size and forecast, by end user
7.4.2.3.4.Market share analysis, for 2019
7.4.2.4.Australia
7.4.2.4.1.Australia market size and forecast, by product
7.4.2.4.2.Australia market size and forecast, by application
7.4.2.4.3.Australia market size and forecast, by end user
7.4.2.4.4.Market share analysis, for 2019
7.4.2.5.South Korea
7.4.2.5.1.South Korea market size and forecast, by product
7.4.2.5.2.South Korea market size and forecast, by application
7.4.2.5.3.South Korea market size and forecast, by end user
7.4.2.5.4.Market share analysis, for 2019
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2.Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3.Rest of Asia-Pacific market size and forecast, by end user
7.4.2.6.4.Market share analysis, for 2019
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil market size and forecast, by product
7.5.2.1.2.Brazil market size and forecast, by application
7.5.2.1.3.Brazil market size and forecast, by end user
7.5.2.1.4.Market share analysis, for 2019
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia market size and forecast, by product
7.5.2.2.2.Saudi Arabia market size and forecast, by application
7.5.2.2.3.Saudi Arabia market size and forecast, by end user
7.5.2.2.4.Market share analysis, for 2019
7.5.2.3.South Africa
7.5.2.3.1.South Arica market size and forecast, by product
7.5.2.3.2.South Arica market size and forecast, by application
7.5.2.3.3.South Arica market size and forecast, by end user
7.5.2.3.4.Market share analysis, for 2019
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA market size and forecast, by product
7.5.2.4.2.Rest of LAMEA market size and forecast, by application
7.5.2.4.3.Rest of LAMEA market size and forecast, by end user
7.5.2.4.4.Market share analysis, for 2019
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product Portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.ARKRAY, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product Portfolio
8.2.4.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.BIONIME CORPORATION
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product Portfolio
8.5.F. HOFFMANN-LA ROCHE LTD.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.LIFESCAN IP HOLDINGS, LLC (PLATINUM EQUITY)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product Portfolio
8.6.4.Key strategic moves and developments
8.7.PHC HOLDINGS CORPORATION
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.TERUMO CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product Portfolio
8.8.5.Business performance
8.9.TRIVIDIA HEALTH, INC. (SINOCARE)
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.10.YPSOMED HOLDING AG
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019-2027 (MILLION UNITS)
TABLE 03.SELF-MONITORING BLOOD GLUCOSE DEVCIES MARKET FOR TEST STRIPS, BY REGION, 2019-2027 ($MILLION)
TABLE 04.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR THE LANCETS, BY REGION, 2019-2027 ($MILLION)
TABLE 05.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR BLOOD GLUCOSE METERS, BY REGION, 2019-2027 ($MILLION)
TABLE 06.GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 07.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, BY REGION, 2019-2027 ($MILLION)
TABLE 08.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2027 ($MILLION)
TABLE 09.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, BY REGION, 2019-2027 ($MILLION)
TABLE 10.GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY END USER, 2019–2027 ($MILLION)
TABLE 11.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, BY REGION, 2019–2027($MILLION)
TABLE 12.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, BY REGION, 2019–2027($MILLION)
TABLE 13.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2019–2027($MILLION)
TABLE 14.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2019–2027($MILLION)
TABLE 15.NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 16.U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 17.U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 18.U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 19.CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 20.CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 21.CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 22.MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 23.MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 24.MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 25.NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 26.NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 27.NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 28.EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 29.GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 30.GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 31.GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 32.FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 33.FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 34.FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 35.UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 36.UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 37.UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 38.ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 39.ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 40.ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 41.SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 42.SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 43.SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 44.REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 45.REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 46.REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 47.EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 48.EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 49.EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 50.ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 51.JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 52.JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 53.JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 54.CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 55.CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 56.CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 57.INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 58.INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 59.INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 60.AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 61.AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 62.AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 64.SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 65.SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 66.REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 67.REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 68.REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 69.ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 70.ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 71.ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 73.BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 74.BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 75.BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 77.SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 78.SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 79.SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 80.SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 81.SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 82.REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 83.REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 84.REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 85.LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2019–2027($MILLION)
TABLE 86.LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 87.LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 88.ABBOTT: COMPANY SNAPSHOT
TABLE 89.ABBOTT: OERATING SEGMENT
TABLE 90.ABBOTT: PRODUCT PORTFOLIO
TABLE 91.ARKRAY: COMPANY SNAPSHOT
TABLE 92.ARKRAY: PRODUCT PORTFOLIO
TABLE 93.B. BRAUN: COMPANY SNAPSHOT
TABLE 94.B. BRAUN: BUSINESS SEGMENTS
TABLE 95.B. BRAUN: PRODUCT PORTFOLIO
TABLE 96.BIONIME: SNAPSHOT
TABLE 97.BIONIME: PRODUCT PORTFOLIO
TABLE 98.ROCHE: COMPANY SNAPSHOT
TABLE 99.ROCHE: OERATING SEGMENT
TABLE 100.ROCHE: PRODUCT PORTFOLIO
TABLE 101.LIFESCAN: COMPANY SNAPSHOT
TABLE 102.LIFESCAN: PRODUCT PORTFOLIO
TABLE 103.PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 104.PHC HOLDINGS CORPORATION: BUSINESS SEGMENTS
TABLE 105.PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 106.TERUMO: COMPANY SNAPSHOT
TABLE 107.TERUMO: OERATING SEGMENT
TABLE 108.TERUMO: PRODUCT PORTFOLIO
TABLE 109.TRIVIDIA HEALTH, INC.: COMPANY SNAPSHOT
TABLE 110.TRIVIDIA HEALTH, INC.: PRODUCT SEGMENTS
TABLE 111.TRIVIDIA HEALTH, INC.: PRODUCT PORTFOLIO
TABLE 112.YPSOMED GROUP: COMPANY SNAPSHOT
TABLE 113.YPSOMED GROUP: OPERATING SEGMENTS
TABLE 114.YPSOMED GROUP: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020*
FIGURE 06.MARKET SHARE ANALYSIS, 2019
FIGURE 07.GLOBAL DIABETES ESTIMATES IN PEOPLE OLDER THAN 65 YEARS IN 2019, 2030 & 2045
FIGURE 08.IMPACT ANALYSES
FIGURE 09.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TEST STRIPS, BY REGION, 2019-2027 (MILLION UNITS)
FIGURE 10.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TEST STRIPS, 2019 & 2027 (%)
FIGURE 11.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR LANCETS, BY REGION, 2019-2027 (MILLION UNITS)
FIGURE 12.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR THE LANCETS, 2019 & 2027 (%)
FIGURE 13.SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR LANCETS, BY REGION, 2019-2027 (MILLION UNITS)
FIGURE 14.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR BLOOD GLUCOSE METERS , 2019 & 2027 (%)
FIGURE 15.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, 2019 & 2027 (%)
FIGURE 21.U.S. SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 22.CANADA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 23.MEXICO SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 24.POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
FIGURE 25.GERMANY SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 26.FRANCE SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 27.UK SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 28.ITALY SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 29.SPAIN SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 30.REST OF EUROPE SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 31.JAPAN SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 32.CHINA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 33.INDIA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 34.AUSTRALIA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 35.SOUTH KOREA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 36.REST OF ASIA PACIFIC SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 37.BRAZIL SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 38.SAUDI ARABIA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 39.SOUTH AFRICA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 40.REST OF LAMEA SELF MONITORING BLOOD GLUCOSE DEVICES MARKET, MARKET SHARE ANALYSIS (%), 2019
FIGURE 41.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.B. BRAUN: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 46.B. BRAUN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 47.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 49.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 50.TERUMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.TERUMO: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 52.TERUMO: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 53.YPSOMED GROUP: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.YPSOMED GROUP: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 55.YPSOMED GROUP: REVENUE SHARE, BY REGION, 2019 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook